JNJ · News · 20260914N

Portfolio Reshaping (M&A / Divestiture)

JOHNSON & JOHNSON · 2026-09-14 · Importance 58 · Surprise 42 · Contradicted

Johnson & Johnson is reportedly in non-binding talks to sell its DePuy Synthes orthopedics business to Apollo Global Management for approximately $20 billion. DePuy Synthes generated $9.3 billion in 2025 sales and includes joint-replacement implants and surgical instruments. The potential transaction follows J&J’s previously announced plan to separate the orthopedics business and would support a greater focus on medicines and higher-growth medical-device activities.

Key facts

• Johnson & Johnson has confirmed it is exploring options to separate its orthopedics business. source
• DePuy Synthes generated $9.3 billion in sales in 2025. source
• Johnson & Johnson stated the move to separate its orthopedics business is not the start of a broader divestiture program. source

Impact estimates